Indivior (INDV)
Develops monthly injectable and sublingual medicines for opioid use disorder.
$36.23
vs last close+0.70 (+1.97%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 101.98% | 120.35M shares | |
|---|---|---|---|
| 348 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 11.01% | 12.99M shares | |
| 14 holders · as of Aug 27, 2026 | |||
| Adds to | 112.99% | ||
118.01M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 112.99%; nothing is left for Other.
13F, as of Jun 30, 2026
348 holders · 120.35M shares · 90 new positions · 207 increased · 109 reduced · 42 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 18.71M | 15.85% | +167.2K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 7.57M | 6.42% | −319.5K | Aug 13, 2026 |
| Oaktree Capital Management LP | 6.13M | 5.19% | −856.9K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 5.50M | 4.66% | −91.1K | Aug 13, 2026 |
| State Street Corp | 4.99M | 4.23% | +88.1K | Aug 7, 2026 |
| Fuller & Thaler Asset Management, Inc. | 4.62M | 3.91% | +86.2K | Aug 12, 2026 |
| Two Seas Capital LP | 3.48M | 2.95% | −1.27M | Aug 12, 2026 |
| Morgan Stanley | 3.40M | 2.88% | −110.1K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.30% | 17.81M | 13G | Jan 8, 2026 |
| Vanguard Portfolio Management | 6.55% | 7.99M | 13G | Apr 28, 2026 |
| The Goldman Sachs Group, Inc. | 6.50% | 8.09M | 13G | Feb 6, 2025 |
| Deerfield Partners, L.P.incl. James E. Flynn, Deerfield Mgmt, L.P. +1 more | 5.80% | 7.36M | 13G | Nov 15, 2024 |
| Oaktree Capital Holdings, LLCincl. Oaktree London Liquid Value Opportunities Fund (VOF), L.P., Oaktree Value Opportunities Fund, L.P. +4 more | 5.69% | 7.11M | 13D | Dec 30, 2025 |
| Vanguard Capital Management | 5.35% | 6.52M | 13G | Apr 27, 2026 |
| Fuller & Thaler Asset Management, Inc. | 5.10% | 6.37M | 13G | Feb 17, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 27, 2026 | Woodrow D. Andersonofficer: Chief Accounting Officer | Purchase | 1,500 | $35.69 | 27,638 |
| Aug 5, 2026 | Woodrow D. Andersonofficer: Chief Accounting Officer | Purchase | 1,500 | $36.28 | 26,138 |
| Jul 10, 2026 | Christian Heidbrederofficer: Chief Scientific Officer | Sale | 18,586 | $41.14 | 209,337 |
| Jun 11, 2026 | Christian Heidbrederofficer: Chief Scientific Officer | Sale | 18,586 | $38.06 | 227,923 |
| Jun 8, 2026 | Ryan Preblickofficer: Chief Financial Officer | Sale | 36,000 | $37.70 | 284,751 |
| Mar 13, 2026 | Barbara Ryandirector | Purchase | 8 | $31.09 | 5,724 |
| Mar 9, 2026 | Barbara Ryandirector | Purchase | 31 | $32.56 | 5,716 |
| Mar 6, 2026 | Stuart A. Kingsleydirector | Purchase | 940 | $31.87 | 5,582 |
| Jan 5, 2026 | David E. Wheadondirector | Purchase | 1,771 | $35.39 | 14,395 |
| Jan 5, 2026 | Mark Stejbachdirector | Purchase | 775 | $35.39 | 16,847 |
House and Senate disclosures
Not reported.